These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo. Meyer J; Timmerman R Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1599-600; author reply 1600. PubMed ID: 21414517 [No Abstract] [Full Text] [Related]
5. Development of single nanometer-sized ultrafine oxygen bubbles to overcome the hypoxia-induced resistance to radiation therapy via the suppression of hypoxia-inducible factor‑1α. Iijima M; Gombodorj N; Tachibana Y; Tachibana K; Yokobori T; Honma K; Nakano T; Asao T; Kuwahara R; Aoyama K; Yasuda H; Kelly M; Kuwano H; Yamanouchi D Int J Oncol; 2018 Mar; 52(3):679-686. PubMed ID: 29393397 [TBL] [Abstract][Full Text] [Related]
6. Response to "Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600). Song CW; Levitt SH; Park H Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1193; author reply 1193-4. PubMed ID: 22036162 [No Abstract] [Full Text] [Related]
7. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results]. Mazeron R; Bourhis J; Deutsch E Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308 [TBL] [Abstract][Full Text] [Related]
8. [Erythropoietin and radiation therapy]. Hennequin C Bull Cancer; 2006 May; 93(5):495-9. PubMed ID: 16777628 [TBL] [Abstract][Full Text] [Related]
9. Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance. Hoogsteen IJ; Marres HA; van den Hoogen FJ; Rijken PF; Lok J; Bussink J; Kaanders JH Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):807-14. PubMed ID: 22420963 [TBL] [Abstract][Full Text] [Related]
10. Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia. Teicher BA Hematol Oncol Clin North Am; 1995 Apr; 9(2):475-506. PubMed ID: 7642474 [TBL] [Abstract][Full Text] [Related]
11. AMPK-independent autophagy promotes radioresistance of human tumor cells under clinical relevant hypoxia in vitro. Chaachouay H; Fehrenbacher B; Toulany M; Schaller M; Multhoff G; Rodemann HP Radiother Oncol; 2015 Sep; 116(3):409-16. PubMed ID: 26318663 [TBL] [Abstract][Full Text] [Related]
12. Elucidating the role of transiently hypoxic tumour cells on radiation resistance. Higgins GS; Hammond EM Br J Cancer; 2022 Apr; 126(7):971-972. PubMed ID: 35197582 [TBL] [Abstract][Full Text] [Related]
13. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment. Nijkamp MM; Span PN; Bussink J; Kaanders JH Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695 [TBL] [Abstract][Full Text] [Related]
14. Targeting the molecular basis for tumour hypoxia. Carroll VA; Ashcroft M Expert Rev Mol Med; 2005 Apr; 7(6):1-16. PubMed ID: 15831177 [TBL] [Abstract][Full Text] [Related]
15. The 5Rs of radiobiology. Steel GG; McMillan TJ; Peacock JH Int J Radiat Biol; 1989 Dec; 56(6):1045-8. PubMed ID: 2574214 [No Abstract] [Full Text] [Related]
16. Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas. Zips D; Le K; Yaromina A; Dörfler A; Eicheler W; Zhou X; Geyer P; Hilberg F; Baumann M Radiother Oncol; 2009 Sep; 92(3):405-10. PubMed ID: 19409639 [TBL] [Abstract][Full Text] [Related]